Office of the Chief Scientist
VC Fund
Tel Aviv, Israel
Office of the Chief Scientist is a VC fund in Tel Aviv focused on Health Care and Biotechnology. The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Office of the Chief Scientist invests in
Stages Office of the Chief Scientist invests in
Countries Office of the Chief Scientist invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $500k–$1M
Investment Focus
Industry
- Health Care 3 (43%)
- Biotechnology 2 (29%)
- Pet 1 (14%)
- Audio 1 (14%)
- AgTech 1 (14%)
Stage
- Seed 4 (57%)
- Grant 2 (29%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Avi Luvton
Executive Director, Asia Pacific Desk, Business Development
|
Executive Director, Asia Pacific Desk, Business Development | Total investments: 0 | Find email | |
|
Haya Miller
Deputy Managing Director
|
Deputy Managing Director | Total investments: 0 | Find email | |
Israel Shamay
Executive Director, Strategic Initiatives, Head of the Americas Operations
|
Executive Director, Strategic Initiatives, Head of the Americas Operations | Total investments: 0 | Find email | |
|
Michel Hiver
Deputy Managing Director
|
Deputy Managing Director | Total investments: 0 | Find email | |
|
Moshe Avrahami
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hargol™ FoodTech
|
Hargol™ FoodTech is the world's first commercial grasshopper farm! Grasshoppers are nature's most efficient protein source.Hargol™ FoodTech revolutionize the protein ingredient industry by providing a healthier and more sustainable and affordable alternative, becoming the leading intensive rearing company of grasshoppers in the world.The company is at the forefront of high quality nutrients and healthy grasshoppers supply to markets around the world, improving current market wild-harvested supply by providing year-round availability, nutrients content & quality and costs reduction.For its first line of products, Hargol FoodTech relies on methods and technologies of intensive breeding and growing of three grasshopper species that are processed into protein powders. The company is offering grasshopper based protein ingredient in North America markets to food/ingredient manufacturers and whole grasshoppers.Hargol™ FoodTech have thus far been attracting the interest of food producers, distributors and retailers in the North America, Europe and other regions of the world with whole grasshoppers, grasshopper’s nutrient-rich powder and innovative food products.With the expected 70% rise in demand for animal source protein over the next decades and with existing animal source protein taking a big toll on the environment there is a need for an alternative – Both sustainable and affordable for populations around the globe.Enhanced by their vegetarian diet grasshoppers’ nutrient content is superior compare to other insects or animal source protein: Over 70% whole protein, Omega-3 & Omega-6, Zinc, Iron, & Folic acid. Grasshoppers are also the only Kosher and Halal insect in the world! | $120K / Grant / Mar 07, 2019 | |
|
Hargol™ FoodTech
|
Hargol™ FoodTech is the world's first commercial grasshopper farm! Grasshoppers are nature's most efficient protein source.Hargol™ FoodTech revolutionize the protein ingredient industry by providing a healthier and more sustainable and affordable alternative, becoming the leading intensive rearing company of grasshoppers in the world.The company is at the forefront of high quality nutrients and healthy grasshoppers supply to markets around the world, improving current market wild-harvested supply by providing year-round availability, nutrients content & quality and costs reduction.For its first line of products, Hargol FoodTech relies on methods and technologies of intensive breeding and growing of three grasshopper species that are processed into protein powders. The company is offering grasshopper based protein ingredient in North America markets to food/ingredient manufacturers and whole grasshoppers.Hargol™ FoodTech have thus far been attracting the interest of food producers, distributors and retailers in the North America, Europe and other regions of the world with whole grasshoppers, grasshopper’s nutrient-rich powder and innovative food products.With the expected 70% rise in demand for animal source protein over the next decades and with existing animal source protein taking a big toll on the environment there is a need for an alternative – Both sustainable and affordable for populations around the globe.Enhanced by their vegetarian diet grasshoppers’ nutrient content is superior compare to other insects or animal source protein: Over 70% whole protein, Omega-3 & Omega-6, Zinc, Iron, & Folic acid. Grasshoppers are also the only Kosher and Halal insect in the world! | $80K / Grant / Feb 15, 2019 | |
GalaPro
|
GalaPro offers an Award winning app that provides Real-time Synchronized Subtitles, Dubbing & Amplification for Theater Shows, Movies, Museums & Conferences using Artificial intelligence and Machine learning. GalaPro was founded by Dr. Elena Litsyn and Hagai Pipko in July 2015. It is based in Herzliya, Israel and New York City | $1M / Grant / Jan 01, 2019 | |
Sqwik - powered by Geev.Me.Tech LTD
|
Sqwik is a new way to create, join & follow fun activities, with new friends, within 3 hours. | $500K / Seed / Aug 01, 2014 | |
LapSpace
|
LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge. | $1M / Seed / Nov 13, 2013 | |
Digma Medical
|
Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGone™ to treat insulin resistance - the underlying mechanism of the disease. TheDiaGone™ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Control™ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGone™ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease. | Seed / Apr 01, 2013 | |
Immunovative Therapies
|
Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease. | $1M / Seed / Jan 01, 2004 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Office of the Chief Scientist invest in?
Office of the Chief Scientist invests primarily in Health Care, Biotechnology and Pet startups, most often at Seed and Grant stage. Most of the 7 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Office of the Chief Scientist's check size?
Office of the Chief Scientist typically joins rounds of $500k–$1M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Office of the Chief Scientist participates in.
How do I contact Office of the Chief Scientist?
Public channels for Office of the Chief Scientist include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Office of the Chief Scientist?
The team at Office of the Chief Scientist includes Avi Luvton (Executive Director, Asia Pacific Desk, Business Development), Haya Miller (Deputy Managing Director) and Israel Shamay (Executive Director, Strategic Initiatives, Head of the Americas Operations), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
